Semaglutide is a prescription medication that may be considered by a licensed healthcare provider as part of an individualized treatment plan when clinically appropriate.
Although semaglutide is often discussed in relation to weight management, healthcare providers consider many factors beyond body weight when evaluating a patient's overall health. Nutrition, physical activity, sleep, hydration, medical history and long-term health goals all play important roles in supporting metabolic wellness.
Understanding how semaglutide interacts with the body's natural GLP-1 hormone pathway can help patients have more informed conversations with their healthcare provider.
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists.
GLP-1 is a naturally occurring hormone released after eating. It participates in communication between the digestive system, pancreas, brain and other organs involved in maintaining normal metabolic function.
Semaglutide interacts with the GLP-1 receptor. A licensed healthcare provider determines whether treatment may be appropriate after reviewing an individual's medical history, current medications, health conditions and treatment goals. Compounded drugs are not FDA approved. This means that the FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.
GLP-1 is one of several hormones involved in the body's complex metabolic system.
Researchers have identified its involvement in several normal physiological processes, including:
These processes work together with many other hormones and organ systems to help maintain normal metabolic function.
Because metabolism is highly individualized, healthcare providers consider the entire clinical picture rather than focusing on one measurement or one treatment option.
Only a licensed healthcare provider can determine whether semaglutide is appropriate for an individual patient.
During an evaluation, a provider may review:
Treatment recommendations should always be based on an individualized medical evaluation.
Prescription medication is only one part of a comprehensive approach to supporting metabolic health.
Ongoing communication with a healthcare provider allows treatment plans to be reviewed and adjusted when appropriate. Follow-up appointments may include discussions about:
Every person's experience is different, making regular follow-up an important part of individualized care.
Healthy daily habits continue to support long-term wellness regardless of the treatment plan selected.
Healthcare providers commonly encourage patients to focus on:
A balanced eating pattern provides essential nutrients that support normal body function.
Depending on an individual's needs, meals may include:
A registered dietitian or qualified nutrition professional may help develop an eating pattern that supports long-term health.
Regular movement supports cardiovascular health, muscular strength, mobility and overall metabolic wellness.
Activities may include:
The appropriate type and amount of activity vary from person to person.
Hydration supports numerous normal physiological processes throughout the body.
Fluid needs vary based on age, activity level, climate, medications and individual health conditions. A healthcare provider can help determine appropriate hydration goals.
Sleep plays an important role in physical recovery, cognitive function and maintaining healthy daily routines.
Developing consistent sleep habits may help support overall health and wellness.
Some patients may receive compounded semaglutide when a licensed healthcare provider determines that a compounded medication is clinically appropriate and legally available.
Compounded drugs are not FDA approved. This means that the FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.
Compounded medications may differ in formulation, inactive ingredients, manufacturing processes and regulatory review. They should not be described as generic, identical or equivalent to an FDA-approved drug product.
Patients should discuss the potential risks, benefits and available treatment options with their healthcare provider.
Semaglutide may be one of several treatment options a licensed healthcare provider considers as part of an individualized care plan.
The decision to prescribe any medication depends on many factors, including your medical history, current health conditions, treatment goals and overall clinical picture.
If you have questions about semaglutide or other treatment options, discuss them with a licensed healthcare provider who can recommend an approach based on your individual needs.
If you're interested in learning more about prescription weight management options, TeleWellnessMD® can connect you with a licensed healthcare provider for an individualized evaluation.
Every treatment plan is personalized based on your health history, goals and clinical needs.
This content is for educational and informational purposes only and should not be interpreted as medical advice. TeleWellnessMD® is a technology platform that connects patients with licensed healthcare providers. TeleWellnessMD® does not practice medicine, provide medical advice, or dispense medications. All therapies require evaluation and approval by a licensed healthcare provider. Results may vary. Prescription required. Compounded drugs are not FDA approved. This means that the FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.